Skip to content
Home/Companies/MedTech/Micromed
Micromed

Micromed

MedTech·France·Exited 2023·Held 7yr
Entry
2016
Hold
7yr
Exit
2023

Who owns Micromed?

Micromed was owned by ARCHIMED through MED I (2014 vintage) from 2016 to 2023, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED I · 2014 · Buyout

Key facts

HQFrance
SectorMedTech
Websitewww.micromed.com
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023

More from MED I

Other portfolio companies in the same fund.

Stago
Stago
Active
MedTechFrance· 2026
Fytexia
Exited 2023
HealthTechFrance· 2016
to
Natural Origins
Natural Origins
Exited 2017
HealthTechFrance· 2016
to
Polyplus
Polyplus
Exited 2023
BiotechFrance· 2016
to
Deallus
Exited 2024
PharmaUK· 2015
to
Primo Group
Primo Group
Exited 2024
HealthTechItaly· 2015
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track Micromed

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Micromed.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue